The behavioral disorders observed in autism are associated with a multitude of genetic alterations. Scientists from the Hector Institute for Translational Brain Research (HITBR) have now found another molecular cause for ...
Feb 13, 2023
0
136
A single-dose of the antiviral drug peginterferon lambda reduced by half the risk of hospitalization or a visit to the Emergency Department due to COVID-19, according to a study published today in the New England Journal ...
Feb 8, 2023
0
123
Investigators have identified new genetic variations effecting gene expression in the liver cells of patients of African ancestry, findings that provide insight into how drugs are metabolized differently in different populations, ...
Feb 8, 2023
0
6
A few days ago, the Australian drug regulator—the Therapeutic Goods Administration (TGA)—surprised experts around the world when it announced the approval of certain psychedelic treatments.
Feb 8, 2023
0
1
New QIMR Berghofer research has found that low-dose aspirin may improve ovarian cancer survival.
Feb 7, 2023
1
108
The best treatment for a genetically driven form of lung cancer continues to show lasting benefits, a new clinical trial update shows.
Feb 6, 2023
0
2
Healing often leaves a scar. But the role of the scar itself in healing is often underestimated: a scar that doesn't heal cleanly can be painful or upsetting or affect the range of movement of the affected body part. It may ...
Feb 1, 2023
0
47
To fight an urgent opioid overdose crisis, a Canadian province took an unusual step on Tuesday.
Jan 31, 2023
0
10
Patients with glioblastoma, a devastating brain cancer, receive treatment that frequently leads to the unfortunate side effect of low white blood cell counts that lasts six months to a year. The low numbers of white blood ...
Jan 30, 2023
0
25
Migraine is a major cause of disability, affecting about 12% of people. A 2-part series published in CMAJ (Canadian Medical Association Journal) on diagnosing and managing the condition with both acute and preventive therapy ...
Jan 30, 2023
0
8
